Cardiovascular Systems, Inc. (CSII): Price and Financial Metrics

Cardiovascular Systems, Inc. (CSII): $20.00

0.03 (+0.15%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

CSII Price/Volume Stats

Current price $20.00 52-week high $20.57
Prev. close $19.97 52-week low $12.26
Day low $19.98 Volume 398,300
Day high $20.00 Avg. volume 765,906
50-day MA $19.82 Dividend yield N/A
200-day MA $15.77 Market Cap 843.96M

CSII Stock Price Chart Interactive Chart >


Cardiovascular Systems, Inc. (CSII) Company Bio


Cardiovascular Systems develops, manufactures, and markets devices for the treatment of vascular diseases, targeting a range of plaque types in leg arteries above and below the knee. The company was founded in 1989 and is based in St. Paul, Minnesota.


CSII Latest News Stream


Event/Time News Detail
Loading, please wait...

CSII Latest Social Stream


Loading social stream, please wait...

View Full CSII Social Stream

Latest CSII News From Around the Web

Below are the latest news stories about CARDIOVASCULAR SYSTEMS INC that investors may wish to consider to help them evaluate CSII as an investment opportunity.

Cytek Biosciences Set to Join S&P SmallCap 600

Cytek Biosciences Inc (NASD:CTKB) will replace Cardiovascular Systems Inc. (NASD:CSII) in the S&P SmallCap 600 effective prior to the opening of trading on Monday, May 1. S&P 500 and 100 constituent Abbott Laboratories (NYSE:ABT) is acquiring Cardiovascular Systems in a deal expected to be completed soon, pending final closing conditions.

Yahoo | April 25, 2023

Cardiovascular Systems, Inc.'s (NASDAQ:CSII) Subdued P/S Might Signal An Opportunity

It's not a stretch to say that Cardiovascular Systems, Inc.'s ( NASDAQ:CSII ) price-to-sales (or "P/S") ratio of 3.5x...

Yahoo | April 19, 2023

Cardiovascular Systems (CSII) Finishes ECLIPSE Trial Enrollment

Cardiovascular Systems' (CSII) ECLIPSE clinical trial data is likely to help physicians form an optimal treatment plan for patients with severely calcified coronary arteries.

Yahoo | April 5, 2023

Cardiovascular Systems, Inc. Completes Enrollment of ECLIPSE Clinical Trial

ST. PAUL, Minn., April 03, 2023--CARDIOVASCULAR SYSTEMS, INC. COMPLETES ENROLLMENT OF ECLIPSE CLINICAL TRIAL

Yahoo | April 3, 2023

Why Is NuVasive (NUVA) Down 15.9% Since Last Earnings Report?

NuVasive (NUVA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Yahoo | March 24, 2023

Read More 'CSII' Stories Here

CSII Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year -53.62%
5-year -53.42%
YTD N/A
2023 0.00%
2022 -27.48%
2021 -57.08%
2020 -9.94%
2019 70.55%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!